查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1622903

全球腹膜透析市场：按治疗类型、按产品类型、按最终用户、按地区、范围和预测

Global Peritoneal Dialysis Market By Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), By Product Type, By End User, By Geographic Scope and Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球腹膜透析市场规模及预测

2024年全球腹膜透析市场规模估值为854.1亿美元，预计2024年至2031年复合年增长率为7.30%，预计2031年达到1500.8亿美元。腹膜透析是一种肾臟替代疗法，利用腹膜（覆盖腹腔的膜）作为天然过滤器来去除血液中的废物和多余的水分。在这种方法中，将无菌透析液注入腹膜腔，使废物经由腹膜吸收，然后排出。

腹膜透析广泛用于慢性肾臟病或等待肾臟移植的患者，具有居家治疗、改善生活品质和生活方式灵活性等优点。

腹膜透析的未来充满希望，技术和解决方案的进步旨在改善患者的治疗效果、提高液体和溶质清除的效率并减少併发症。

全球腹膜透析市场动态

塑造全球腹膜透析市场的主要市场动态

主要市场推动因素

慢性肾臟病 (CKD) 盛行率上升：

慢性肾臟病（CKD）盛行率上升：慢性肾臟病患者病率上升是透析治疗需求的主要驱动力。根据美国疾病管制与预防中心 (CDC) 的数据，估计美国约有 3,700 万成年人患有 CKD，其中很大一部分需要透析。

老化进展：

人口老化是腹膜透析市场扩大的关键因素。世界卫生组织 (WHO) 预测，到 2050 年，全球 60 岁及以上人口将达到 20 亿，预计将增加肾臟相关疾病的盛行率和透析选择的需求。

转向居家照护：

居家透析已成为一种值得注意的趋势，因为它为患者提供了便利性和自主性。美国肾臟数据系统 (USRDS) 报告称，截至 2020 年，美国约 8% 的透析患者使用腹膜透析，这反映出人们越来越倾向于居家治疗。

技术进步：

腹膜透析设备和解决方案的创新正在提高治疗效率和患者治疗效果。根据国际腹膜透析协会的报告，新的自动化系统和改进的透析解决方案有可能提高患者的接受度和满意度并推动市场成长。2022年腹膜透析市场规模预估为45亿美元，至2030年复合年增长率（CAGR）为6.5%。

主要课题

感染风险：腹膜透析具有很高的感染风险，尤其是腹膜炎，这使得治疗变得复杂并可能导致严重的健康问题。这些风险可能会阻止患者选择腹膜透析而不是血液透析。

病患教育与训练：有效实施腹膜透析需要适当的病患教育和培训，以实现成功的家庭治疗。许多患者可能缺乏获得必要技能所需的支持和资源，这可能会影响依从性和治疗结果。

取得和负担能力：在某些地区，特别是在低收入和农村地区，获得腹膜透析的机会可能受到限制。此外，与设备、用品和医疗保健服务相关的高成本可能成为寻求这种治疗的患者的障碍。

心理社会因素：焦虑、忧郁和社会孤立等心理因素会影响患者接受居家透析的意愿。解决这些社会心理课题对于提高治疗依从性和生活品质至关重要。

主要趋势

数位医疗技术的整合：远距医疗和远端监控技术的引入正在加强腹膜透析的患者管理和后续护理。这些创新透过提高对治疗方案的依从性并允许及时干预来改善患者的治疗结果。

个人化治疗方法：在腹膜透析中，个人化医疗的趋势日益增长，即根据每位患者的需求量身订做治疗计画。这包括根据患者特定参数调整透析液和时间表，从而提高疗效和满意度。

扩大病患教育计画：针对病患和医疗保健提供者的强化教育计画变得越来越普遍。此类计划的重点是对患者进行有关腹膜透析程序、潜在併发症和管理策略的教育，从而提高依从性和治疗结果。

加强研究和开发：继续研究改良腹膜透析液和机器是当务之急。该公司正在投资开发新型生物相容性腹膜透析液和自动化系统，以提高腹膜透析的效率和安全性，并有望在未来几年上市的产品。

目录

第1章 全球腹膜透析市场简介

  • 市场概况
  • 调查范围
  • 先决条件

第 2 章执行摘要

第3章 验证市场研究研究方法

  • 数据挖掘
  • 验证
  • 一次资料
  • 数据源列表

第4章 全球腹膜透析市场展望

  • 概述
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力模型
  • 价值链分析

第5章全球腹膜透析市场：依治疗类型

  • 概述
  • 连续性门诊腹膜透析（CAPD）
  • 自动腹膜透析（APD）

第6章全球腹膜透析市场：依产品类型

  • 概述
  • 腹膜透析液
  • 腹膜透析装置
  • 腹膜透析仪
  • 导管
  • 其他

第7章全球腹膜透析市场：依最终使用者分类

  • 概述
  • 家庭透析
  • 透析中心及医院透析

第8章全球腹膜透析市场：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区
    • 拉丁美洲
    • 中东/非洲

第9章 全球腹膜透析市场竞争状况

  • 概述
  • 各公司市场排名
  • 主要发展策略

第10章 公司简介

  • Baxter International Inc.
  • Fresenius Medical Care
  • NxStage Medical Inc.
  • DaVita Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Minntech Corporation
  • Maruho Co., Ltd.
  • Terumo Corporation

第11章 主要进展

  • 产品发布/开发
  • 併购
  • 业务拓展
  • 伙伴关係和联盟

第12章附录

  • 相关研究
简介目录
Product Code: 5350

Global Peritoneal Dialysis Market Size and Forecast

Global Peritoneal Dialysis Market size was valued at USD 85.41 Billion in 2024 and is projected to reach USD 150.08 Billion by 2031 , growing at a CAGR of 7.30% from 2024 to 2031. Peritoneal Dialysis is a renal replacement therapy that utilizes the peritoneum, a membrane lining the abdominal cavity, as a natural filter to remove waste products and excess fluids from the bloodstream. This method involves the infusion of a sterile dialysis solution into the abdominal cavity, where it absorbs waste through the peritoneal membrane and is then drained out.

Widely used for patients with chronic kidney disease or those awaiting kidney transplantation, peritoneal dialysis offers the advantages of home-based treatment, improved quality of life, and flexibility in lifestyle.

The future of peritoneal dialysis looks promising, with advancements in technology and solutions aimed at enhancing patient outcomes, increasing the efficiency of fluid and solute removal, and reducing complications.

Global Peritoneal Dialysis Market Dynamics

The key market dynamics that are shaping the global peritoneal dialysis market include:

Key Market Drivers:

Rising Prevalence of Chronic Kidney Disease (CKD):

The increasing incidence of chronic kidney disease significantly drives the demand for dialysis treatments. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a significant proportion requiring dialysis.

Growing Aging Population:

The aging population is a critical factor in the expansion of the peritoneal dialysis market. The World Health Organization (WHO) projects that the global population aged 60 years and older will reach 2 billion by 2050, which is expected to increase the prevalence of kidney-related diseases and the need for dialysis options.

Shift Toward Home-Based Care:

There is a notable trend toward home-based dialysis solutions due to the convenience and autonomy they offer patients. According to a report from the United States Renal Data System (USRDS), as of 2020, approximately 8% of all dialysis patients in the U.S. were using peritoneal dialysis, reflecting a growing preference for home therapies.

Technological Advancements:

Innovations in peritoneal dialysis equipment and solutions are enhancing treatment efficiency and patient outcomes. The International Society for Peritoneal Dialysis reported that new automated systems and improved dialysis solutions have the potential to increase patient acceptance and satisfaction, driving market growth. In 2022, the peritoneal dialysis market was valued at $4.5 billion and is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2030.

Key Challenges:

Infection Risks: Peritoneal dialysis is associated with a higher risk of infections, particularly peritonitis, which can complicate treatment and lead to severe health issues. This risk can deter patients from choosing this modality over hemodialysis.

Patient Education and Training: Effective peritoneal dialysis requires proper patient education and training to ensure successful home-based treatment. Many patients may lack the necessary support or resources to learn the required techniques, which can affect compliance and outcomes.

Access and Affordability: Access to peritoneal dialysis can be limited in certain regions, particularly in low-income or rural areas. Additionally, high costs associated with equipment, supplies, and healthcare services can pose a barrier for patients seeking this treatment.

Psychosocial Factors: Psychological aspects such as anxiety, depression, and social isolation can impact patients' willingness to engage in home dialysis. Addressing these psychosocial challenges is essential for improving treatment adherence and quality of life.

Key Trends:

Integration of Digital Health Technologies: The incorporation of telehealth and remote monitoring technologies is enhancing patient management and follow-up care in peritoneal dialysis. These innovations allow for better adherence to treatment protocols and timely intervention, thereby improving patient outcomes.

Personalized Treatment Approaches: There is a growing trend toward personalized medicine in peritoneal dialysis, where treatment plans are tailored to individual patient needs. This includes adjusting dialysis solutions and schedules based on patient-specific parameters, which can improve efficacy and satisfaction.

Expansion of Patient Education Programs: Enhanced educational initiatives aimed at both patients and healthcare providers are becoming more common. These programs focus on training patients about peritoneal dialysis procedures, potential complications, and management strategies, leading to better compliance and outcomes.

Increased Research and Development: Ongoing research efforts to improve peritoneal dialysis solutions and equipment are being prioritized. Companies are investing in developing new biocompatible solutions and automated systems to enhance the efficiency and safety of peritoneal dialysis, with several promising products expected to enter the market in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Peritoneal Dialysis Market Regional Analysis

Here is a more detailed regional analysis of the global peritoneal dialysis market:

North America:

North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a substantial proportion requiring dialysis treatment, driving the demand for peritoneal dialysis.

The presence of key market players, such as Baxter International and Fresenius Medical Care, further strengthens North America's leading position in the peritoneal dialysis market. In 2023, the North American market for peritoneal dialysis was valued at approximately $1.2 billion, reflecting a robust growth trajectory fueled by technological advancements and increased patient education regarding home-based treatment options.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases. According to the National Kidney Foundation, the prevalence of kidney disease in India is expected to reach 200 million by 2030, highlighting the urgent need for effective treatment solutions.

Technological advancements and collaborations between healthcare providers and manufacturers also fuel market growth in the Asia Pacific region. In 2023, the Asia Pacific peritoneal dialysis market was valued at approximately $600 million, and it is projected to grow at a compound annual growth rate (CAGR) of over 10% through the next five years.

Global Peritoneal Dialysis Market: Segmentation Analysis

The Global Peritoneal Dialysis Market is segmented on the basis of By Treatment Type, By Product Type, By End User, and By Geography.

Global Peritoneal Dialysis Market, By Treatment Type

  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Based on Treatment Type, the Global Peritoneal Dialysis Market is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Continuous Ambulatory Peritoneal Dialysis (CAPD) is the dominating segment due to its simplicity and the ability for patients to manage their treatments independently without the need for machines. However, Automated Peritoneal Dialysis (APD) is the fastest-growing segment, driven by advancements in technology and the increasing demand for more convenient and efficient treatment options.

Global Peritoneal Dialysis Market, By Product Type

  • Peritoneal Dialysis Solution Device
  • Peritoneal Dialysis Set
  • Catheter

Based on Product Type, the Global Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution Device, Peritoneal Dialysis Set and Catheter. The Peritoneal Dialysis Solution Device is the dominating segment due to its essential role in the dialysis process and the high demand for effective dialysis solutions. However, the Peritoneal Dialysis Set segment is the fastest-growing, driven by increasing adoption rates of home-based dialysis and advancements in technology that enhance user convenience and treatment efficacy.

Global Peritoneal Dialysis Market, By End User

  • Home-based Dialysis
  • Dialysis Center & Hospital-based Dialysis

Based on End User, the Global Peritoneal Dialysis Market is segmented into Home-based Dialysis and Dialysis Center & Hospital-based Dialysis. Home-based dialysis is the dominating segment due to its convenience and patient autonomy, allowing individuals to manage their treatment in the comfort of their homes. However, the fastest-growing segment is hospital-based dialysis, driven by advancements in technology, improved treatment options, and increasing awareness among healthcare providers about the benefits of in-center treatment for patients with complex medical needs.

Global Peritoneal Dialysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Peritoneal Dialysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases.

Key Players

  • The "Global Peritoneal Dialysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
  • Fresenius Medical Care, Baxter International Inc., NxStage Medical Inc., DaVita Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Braun Melsungen AG, Minntech Corporation, Maruho Co., Ltd., Terumo Corporation, Fresenius Kabi, Bellco Medical LLC, Vascular Solutions, Inc., Medtronic plc, Quanta Dialysis Technologies Ltd., Dialysis Clinic, Inc., US Renal Care, FMC Corporation, Amicus Therapeutics, Inc.
  • Our
  • market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
  • Global Peritoneal Dialysis Market: Recent Developments
  • In August 2024 Baxter International revealed plans to expand its manufacturing facilities for peritoneal dialysis products in response to increasing global demand. The expansion will enhance the company's production capacity and improve supply chain efficiency, allowing for quicker distribution of their innovative dialysis solutions.
  • In July 2024 Medtronic announced a collaboration with several digital health companies to integrate remote monitoring capabilities into its peritoneal dialysis devices. This partnership aims to enhance patient engagement and streamline treatment management through real-time data sharing between patients and healthcare providers.
  • In June 2024 Terumo Corporation unveiled new research initiatives focused on developing advanced peritoneal dialysis products that utilize biocompatible materials.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PERITONEAL DIALYSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PERITONEAL DIALYSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL PERITONEAL DIALYSIS MARKET, BY TREATMENT TYPE

  • 5.1 Overview
  • 5.2 Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • 5.3 Automated Peritoneal Dialysis (APD)

6 GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCT TYPE

  • 6.1 Overview
  • 6.2 Peritoneal Dialysis Solution
  • 6.3 Device
  • 6.4 Peritoneal Dialysis Set
  • 6.5 Catheter
  • 6.6 Others

7 GLOBAL PERITONEAL DIALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Home-based Dialysis
  • 7.3 Dialysis Center & Hospital-based Dialysis

8 GLOBAL PERITONEAL DIALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL PERITONEAL DIALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Baxter International Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Fresenius Medical Care
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 NxStage Medical Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 DaVita Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Asahi Kasei Medical Co., Ltd.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Nipro Corporation
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 B. Braun Melsungen AG
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Minntech Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Maruho Co., Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Terumo Corporation
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research